Infection and atherosclerosis - Focus on cytomegalovirus and Chlamydia pneumoniae

Annals of Pharmacotherapy

Volumn 32, Issue 12, 1998, Pages 1310-1316

  Cheng, Judy W M ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Cytomegalovirus

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CIDOFOVIR; CLARITHROMYCIN; CYTOMEGALOVIRUS VACCINE; ERYTHROMYCIN; FOSCARNET; GANCICLOVIR; MACROLIDE; ROXITHROMYCIN;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY ATHEROSCLEROSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; LEUKOCYTE ADHERENCE; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SEROEPIDEMIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; ARTERIOSCLEROSIS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS INFECTIONS; HUMANS; RECURRENCE;

EID: 0032441016     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18057     Document Type: Review

References (4)

1. Gillum RF. Trends in acute myocardial infarction and coronary heart disease death in United States. J Am Coll Cardiol 1994:23:1273-7.
2. Wittels EH, Hay JW, Gotto AM. Medical costs of coronary artery disease in the United States. Am J Cardiol 1990;65:432-40.
3. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease. N Engl J Med 1995;332:512-21.
4. Sytkowski PA, Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment and cardiovascular mortality. Circulation 1996;93:697-703.